• Saved

November 06, 2022
The impact of patient travel time on disparities in treatment for early stage lung cancer in California

The impact of patient travel time on disparities in treatment for early stage lung cancer in California

Source : https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0272076

Background Travel time to treatment facilities may impede the receipt of guideline-concordant treatment (GCT) among patients diagnosed with early-stage non-small cell lung cancer (ES-NSCLC). We investigated the relative contribution of travel time in the receipt of GCT among ES-NSCLC patients. Methods We included 22,821 ES-NSCLC patients diagnosed in California from 2006-2015.


Conclusion: The benefit of GCT observed with increased travel times may be a ‘Travel Time Paradox,’ and may vary across racial/ethnic and socioeconomic groups.

  • November 06, 2022
    obviously the further people live the harder is to get